J&J's Guselkumab Nears Crowded EU Psoriasis Market After CHMP OK

 
• By John Davis

Janssen-Cilag/MorphoSys's potential first-in-class psoriasis therapy has received a positive approval recommendation from Europe's top scientific advisory panel, and could become a blockbuster product despite the cluttered and changeable state of the dermatology sector.

Psoriasis
psoriasis is an itchy and painful condition • Source: Shutterstock

More from New Products

More from Scrip